Stocktoria

EyePoint, Inc. EYPT

Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2005-01-27 · LEI

EyePoint, Inc. financials (annual)

Revenue
$7.5M $3.0M $4.6M $20.4M $34.4M $36.9M $41.4M $46.0M $43.3M $31.4M 2017201820182019202020212022202320242025
Net income
-$18.5M -$53.2M -$86.1M -$56.8M -$45.4M -$58.4M -$102.3M -$70.8M -$130.9M -$232.0M 2017201820182019202020212022202320242025
Free cash flow
-$20.6M -$22.0M -$56.9M -$14.8M -$50.3M -$67.2M -$1.6M -$130.3M -$243.4M 2017201820182019202020212022202320242025

Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017
Revenue$31.4M$43.3M$46.0M$41.4M$36.9M$34.4M$20.4M$4.6M$3.0M$7.5M
R&D expense$221.0M$132.9M$64.7M$49.6M$28.5M$17.4M$15.4M$18.5M$16.2M$14.9M
Operating income-$243.4M-$145.9M-$75.1M-$99.6M-$55.3M-$37.3M-$47.9M-$39.0M-$26.3M-$18.6M
Interest expense$1.2M$3.2M$5.5M$7.3M$6.2M$2.4M$720,000$0
Income tax$279,000$90,000$83,000$0$0$0$0$0$0
Net income-$232.0M-$130.9M-$70.8M-$102.3M-$58.4M-$45.4M-$56.8M-$86.1M-$53.2M-$18.5M
EPS (diluted)$-3.17$-2.32$-1.82$-2.74$-2.03$-0.52
Operating cash flow-$240.1M-$126.2M$1.9M-$65.0M-$50.1M-$14.4M-$56.7M-$21.9M-$20.5M
Free cash flow-$243.4M-$130.3M-$1.6M-$67.2M-$50.3M-$14.8M-$56.9M-$22.0M-$20.6M
Cash & equivalents$101.8M$99.7M$281.3M$95.6M$178.6M$44.9M$22.2M$45.3M$38.8M$16.9M
Inventory$1.8M$2.3M$3.9M$2.9M$3.6M$5.3M$2.1M$279,000
Total assets$364.0M$418.5M$355.2M$180.4M$263.4M$91.7M$73.0M$78.2M$71.7M$18.7M
Total liabilities$57.9M$82.0M$88.9M$84.0M$79.0M$73.2M$64.6M$40.5M$60.0M$5.3M
Shareholders' equity$306.1M$336.5M$266.3M$96.4M$184.4M$18.5M$8.3M$37.6M$11.7M$13.3M

Growth · year-over-year · Revenue CAGR 17.2%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017
Revenue growth-27.5%-6.0%+11.1%+12.1%+7.3%+69.1%+345.5%+54.4%-60.7%+365.4%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.